Is Revisional Gastric Bypass as Effective as Primary Gastric Bypass for Weight Loss and Improvement of Comorbidities?
- PMID: 31865551
- DOI: 10.1007/s11695-019-04280-x
Is Revisional Gastric Bypass as Effective as Primary Gastric Bypass for Weight Loss and Improvement of Comorbidities?
Abstract
Background: Revisional gastric bypass (R-RYGB) surgery is utilized for the management of inadequate weight loss or weight regain observed after some cases of bariatric surgeries. Data on the mid-term effectiveness of primary gastric bypass (P-RYGB) compared with R-RYGB (e.g., post sleeve gastrectomy/gastric banding) are controversial.
Methods: Retrospective chart review of all patients who received P-RYGB and R-RYGB (January 2011-June 2015) at our center. One hundred twenty patients who underwent P-RYGB and 34 R-RYGB who completed 18 months follow-up were included. We compared the effectiveness of P-RYGB with R-RYGB by assessing four anthropometric, two glycemic, and four lipid parameters, as well as the control of type 2 diabetes (T2DM), hypertension, dyslipidemia (remission, improvement, persistence, relapse, de novo), mortality and complications rates.
Results: A comparison of the effectiveness of P-RYGB with R-RYGB at 18 months revealed no significant differences in patients' age, gender, and preoperative BMI between groups. However, patients who received P-RYGB had lower mean weight (P = 0.001) and BMI (P < 0.001), reflected by a higher mean delta BMI (P = 0.02), total weight loss percentage (TWL%) (P < 0.0001) and excess weight loss percentage (EWL%) (P < 0.0001). No differences in glycemic parameters, lipid profiles, control of T2DM, hypertension, and dyslipidemia were observed. No death is reported and complication rates were comparable.
Conclusions: Although R-RYGB effectively addressed inadequate weight loss, weight regain, and recurrence of comorbidities after restrictive bariatric surgery, R-RYGB resulted in inferior weight loss compared with P-RYGB. Neither procedure differed in their clinical control of T2DM, hypertension, and dyslipidemia. Both procedures exhibited comparable complication rates.
Keywords: Dyslipidemia; Hypertension; Primary gastric bypass; Revisional gastric bypass; Type 2 diabetes; Weight loss outcome.
Similar articles
-
Revisional Gastric Bypass for Failed Restrictive Procedures: Comparison of Single-Anastomosis (Mini-) and Roux-en-Y Gastric Bypass.Obes Surg. 2018 Apr;28(4):970-975. doi: 10.1007/s11695-017-2991-0. Obes Surg. 2018. PMID: 29101719
-
Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.Surg Endosc. 2019 Feb;33(2):401-410. doi: 10.1007/s00464-018-6307-9. Epub 2018 Jun 25. Surg Endosc. 2019. Retraction in: Surg Endosc. 2021 Mar;35(3):1492. doi: 10.1007/s00464-021-08298-0. PMID: 29943058 Retracted. Clinical Trial.
-
One anastomosis gastric bypass vs. Roux-en-Y gastric bypass, remedy for insufficient weight loss and weight regain after failed restrictive bariatric surgery.Obes Surg. 2020 Sep;30(9):3287-3294. doi: 10.1007/s11695-020-04536-x. Obes Surg. 2020. PMID: 32307669 Free PMC article.
-
Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies.Int J Surg. 2020 Apr;76:101-110. doi: 10.1016/j.ijsu.2020.02.035. Epub 2020 Mar 6. Int J Surg. 2020. PMID: 32151750
-
Single- or double-anastomosis duodenal switch versus Roux-en-Y gastric bypass as a revisional procedure for sleeve gastrectomy: A systematic review and meta-analysis.Surg Obes Relat Dis. 2019 Apr;15(4):556-566. doi: 10.1016/j.soard.2019.01.022. Epub 2019 Jan 31. Surg Obes Relat Dis. 2019. PMID: 30837111
Cited by
-
Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass: Is Intrathoracic Migration of the Sleeve of High Incidence?Obes Surg. 2024 Aug;34(8):2907-2913. doi: 10.1007/s11695-024-07341-y. Epub 2024 Jul 8. Obes Surg. 2024. PMID: 38976187
-
Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: An Updated Comprehensive Practical Guideline.Obes Surg. 2023 Aug;33(8):2557-2572. doi: 10.1007/s11695-023-06703-2. Epub 2023 Jun 30. Obes Surg. 2023. PMID: 37389806 Review.
-
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis.Obes Surg. 2025 Mar;35(3):808-822. doi: 10.1007/s11695-025-07733-8. Epub 2025 Feb 13. Obes Surg. 2025. PMID: 39948306
-
Definition, Mechanisms and Predictors of Weight Loss Failure After Bariatric Surgery.J Metab Bariatr Surg. 2022 Dec;11(2):39-48. doi: 10.17476/jmbs.2022.11.2.39. Epub 2023 Feb 3. J Metab Bariatr Surg. 2022. PMID: 36926678 Free PMC article. Review.
-
SMALL INTESTINAL L CELL DENSITY IN PATIENTS WITH SEVERE OBESITY AFTER ROUX-EN-Y GASTRIC BYPASS.Arq Bras Cir Dig. 2022 Oct 3;35:e1681. doi: 10.1590/0102-672020220002e1681. eCollection 2022. Arq Bras Cir Dig. 2022. PMID: 36197372 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical